These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 16275661

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
    Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ, Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group.
    N Engl J Med; 2002 Dec 05; 347(23):1834-40. PubMed ID: 12466507
    [Abstract] [Full Text] [Related]

  • 3. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr 05; 13(70):64-9. PubMed ID: 15148984
    [Abstract] [Full Text] [Related]

  • 4. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, Mickel M, Barrell P, AFFIRM Investigators.
    Am Heart J; 2005 Apr 05; 149(4):657-63. PubMed ID: 15990749
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Does intensity of rate control influence outcome in persistent atrial fibrillation? Data of the RACE study.
    Groenveld HF, Crijns HJ, Rienstra M, Van den Berg MP, Van Veldhuisen DJ, Van Gelder IC, RACE investigators.
    Am Heart J; 2009 Nov 05; 158(5):785-91. PubMed ID: 19853699
    [Abstract] [Full Text] [Related]

  • 9. AFFIRM and RACE trials: implications for the management of atrial fibrillation.
    Blackshear JL, Safford RE, AFFIRM trial, RACE trial.
    Card Electrophysiol Rev; 2003 Dec 05; 7(4):366-9. PubMed ID: 15071255
    [Abstract] [Full Text] [Related]

  • 10. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.
    Sherman DG, Kim SG, Boop BS, Corley SD, Dimarco JP, Hart RG, Haywood LJ, Hoyte K, Kaufman ES, Kim MH, Nasco E, Waldo AL, National Heart, Lung, and Blood Institute AFFIRM Investigators.
    Arch Intern Med; 2005 May 23; 165(10):1185-91. PubMed ID: 15911734
    [Abstract] [Full Text] [Related]

  • 11. Atrial fibrillation: rhythm control offers no advantage over rate control for some, but not all.
    Li YB, Hu CL, Liu J, Chen YX, Qu Z, Xu JL, Chen JB, Wan J, Tang QZ, Huang CX.
    Med Hypotheses; 2007 May 23; 69(1):206-8. PubMed ID: 17011138
    [Abstract] [Full Text] [Related]

  • 12. Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study.
    Curtis AB, Seals AA, Safford RE, Slater W, Tullo NG, Vidaillet H, Wilber DJ, Slee A.
    Am Heart J; 2005 Feb 23; 149(2):304-8. PubMed ID: 15846269
    [Abstract] [Full Text] [Related]

  • 13. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation.
    Nieuwlaat R, Prins MH, Le Heuzey JY, Vardas PE, Aliot E, Santini M, Cobbe SM, Widdershoven JW, Baur LH, Lévy S, Crijns HJ.
    Eur Heart J; 2008 May 23; 29(9):1181-9. PubMed ID: 18397874
    [Abstract] [Full Text] [Related]

  • 14. Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion (RACE) study.
    Hagens VE, Vermeulen KM, TenVergert EM, Van Veldhuisen DJ, Bosker HA, Kamp O, Kingma JH, Tijssen JG, Crijns HJ, Van Gelder IC, RACE study group.
    Eur Heart J; 2004 Sep 23; 25(17):1542-9. PubMed ID: 15342174
    [Abstract] [Full Text] [Related]

  • 15. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Jenkins LS, Brodsky M, Schron E, Chung M, Rocco T, Lader E, Constantine M, Sheppard R, Holmes D, Mateski D, Floden L, Prasun M, Greene HL, Shemanski L.
    Am Heart J; 2005 Jan 23; 149(1):112-20. PubMed ID: 15660042
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Curtis AB, Gersh BJ, Corley SD, DiMarco JP, Domanski MJ, Geller N, Greene HL, Kellen JC, Mickel M, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG, AFFIRM Investigators.
    Am Heart J; 2005 Apr 23; 149(4):645-9. PubMed ID: 15990747
    [Abstract] [Full Text] [Related]

  • 18. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G, Diemberger I, Biffi M, Domenichini G, Martignani C, Valzania C, Branzi A.
    Int J Clin Pract; 2007 May 23; 61(5):748-56. PubMed ID: 17493088
    [Abstract] [Full Text] [Related]

  • 19. Management of atrial fibrillation in the elderly.
    Aronow WS.
    Minerva Med; 2009 Feb 23; 100(1):3-24. PubMed ID: 19182738
    [Abstract] [Full Text] [Related]

  • 20. Rate control versus rhythm control.
    Vidaillet H, Greenlee RT.
    Curr Opin Cardiol; 2005 Jan 23; 20(1):15-20. PubMed ID: 15596954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.